Your browser doesn't support javascript.
loading
An abluminal biodegradable polymer sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients undergoing coronary revascularization: 3-year clinical outcomes of a randomized non-inferiority trial.
Zhang, Haijun; Zhang, Xiaoping; Yin, Yuxia; Zhou, Chao; Deng, Wei; Zhang, Junwei; Hou, Wenbo; Lu, Shoutao; Song, Caixia; Cui, Xiaoshan; Wang, Shenguo; Yang, Fei; Liu, Guang; Duan, Cuihai; Ge, Junbo.
Affiliation
  • Zhang H; Intervention & Vascular Surgery, Medical College of Tongji University, Shanghai, China.
  • Zhang X; Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg Ø, Denmark.
  • Yin Y; National Joint Engineering Laboratory for Biomedical Material Modification, Shandong, China.
  • Zhou C; Intervention & Vascular Surgery, Medical College of Tongji University, Shanghai, China. zxpkxy@tongji.edu.cn.
  • Deng W; National Joint Engineering Laboratory for Biomedical Material Modification, Shandong, China.
  • Zhang J; National Joint Engineering Laboratory for Biomedical Material Modification, Shandong, China.
  • Hou W; Key Laboratory of Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai, China.
  • Lu S; National Joint Engineering Laboratory for Biomedical Material Modification, Shandong, China.
  • Song C; National Joint Engineering Laboratory for Biomedical Material Modification, Shandong, China.
  • Cui X; National Joint Engineering Laboratory for Biomedical Material Modification, Shandong, China.
  • Wang S; National Joint Engineering Laboratory for Biomedical Material Modification, Shandong, China.
  • Yang F; National Joint Engineering Laboratory for Biomedical Material Modification, Shandong, China.
  • Liu G; Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.
  • Duan C; Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.
  • Ge J; National Joint Engineering Laboratory for Biomedical Material Modification, Shandong, China.
Sci Rep ; 9(1): 18549, 2019 12 06.
Article in En | MEDLINE | ID: mdl-31811206

Full text: 1 Collection: 01-internacional Health context: 11_ODS3_cobertura_universal / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Sirolimus / Coronary Stenosis / Drug-Eluting Stents / Percutaneous Coronary Intervention / Everolimus Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Sci Rep Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 11_ODS3_cobertura_universal / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Sirolimus / Coronary Stenosis / Drug-Eluting Stents / Percutaneous Coronary Intervention / Everolimus Type of study: Clinical_trials / Etiology_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Sci Rep Year: 2019 Document type: Article